1. Home
  2. Labeler Index
  3. Amring Pharmaceuticals Inc.
  4. 69918-300
  5. NDC Package Code: 69918-300-30 Lysteda

NDC Package 69918-300-30 Lysteda

Tranexamic Acid Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69918-300-30
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
69918-300
Proprietary Name:
Lysteda
Non-Proprietary Name:
Tranexamic Acid
Substance Name:
Tranexamic Acid
Usage Information:
This medication is used to treat heavy bleeding during your menstrual period. Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. It belongs to a class of drugs known as antifibrinolytics. Tranexamic acid is not a hormone. It does not treat other menstrual or pre-menstrual symptoms. It does not stop your period. It is not a form of birth control and does not protect against sexually transmitted diseases.
11-Digit NDC Billing Format:
69918030030
NDC to RxNorm Crosswalk:
  • RxCUI: 883826 - tranexamic acid 650 MG Oral Tablet
  • RxCUI: 883830 - Lysteda 650 MG Oral Tablet
  • RxCUI: 883830 - tranexamic acid 650 MG Oral Tablet [Lysteda]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Amring Pharmaceuticals Inc.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • TRANEXAMIC ACID 650 mg/1
    • Pharmacologic Class(es):
  • Antifibrinolytic Agent - [EPC] (Established Pharmacologic Class)
  • Decreased Fibrinolysis - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    NDA022430
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-17-2010
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69918-300-30?

    The NDC Packaged Code 69918-300-30 is assigned to a package of 30 tablet in 1 bottle of Lysteda, a human prescription drug labeled by Amring Pharmaceuticals Inc.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 69918-300 included in the NDC Directory?

    Yes, Lysteda with product code 69918-300 is active and included in the NDC Directory. The product was first marketed by Amring Pharmaceuticals Inc. on May 17, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69918-300-30?

    The 11-digit format is 69918030030. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-269918-300-305-4-269918-0300-30